BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• EOS imaging Announces New Installation in a Top-Ranking Specialty Orthopedic Hospital in China

  EOS imaging today announced the installation of an EOS system at the Beijing Jishuitan Hospital in Beijing Shi, China.

  February 6, 2018

   · 

  2 min read
• Drug Development

  ContraVir Pharmaceuticals Completes Renal Impairment Study With TXL

  The study of 16 subjects included 8 healthy subjects with normal kidney function and 8 subjects with severely impaired kidney function.

  February 6, 2018

   · 

  3 min read
• Genetown

  FDNA Grants Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, UK as Center of Research Excellence; Advancing Next-Generation Phenotyping for Genetics Evaluations

  The grant provides funding to researchers to advance next-generation phenotyping (NGP) and facial analysis technology at luminary sites working on precision medicine.

  February 6, 2018

   · 

  3 min read
• Business

  Applied DNA and TheraCann International Conduct Successful Tagging and Testing Pilot of Legal Cannabis and Derivative-Products

  Applied DNA announced today that in conjunction with TheraCann International Benchmark Corporation, it has had early success in the tagging and authentication of legal cannabis and its derivatives in a laboratory pilot.

  February 6, 2018

   · 

  5 min read
• Business

  Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website

  Haemonetics announced that third quarter and year-to-date fiscal 2018 financial results are available on its Investor relations website.

  February 6, 2018

   · 

  1 min read
• Bio NC

  Marken Accelerates its Reach and Growth In Clinical Trial Logistics

  Marken expanded its geographic reach and product portfolio in 2017, reinforcing its position as a leader in clinical trial logistics and supply chain services.

  February 6, 2018

   · 

  3 min read
• Business

  BD Announces Results for 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated for Inclusion of Bard

  BD today reported quarterly revenues of $3.080 billion for the first fiscal quarter ended December 31, 2017.

  February 6, 2018

   · 

  32 min read
• MeMed Secures Additional Funding From the Department of Defense

  MeMed announced today that it has been awarded a $4,079,159 grant by the DoD’s CDMRP.

  February 6, 2018

   · 

  3 min read
• Business

  AmerisourceBergen Reports Fiscal 2018 First Quarter Results

  AmerisourceBergen Corporation today reported that in its fiscal year 2018 first quarter ended December 31, 2017, revenue increased 6.0 percent to $40.5 billion.

  February 6, 2018

   · 

  34 min read
• Compugen Announces Publication of the Discovery of ILDR2 as a Novel Immune Checkpoint and its Use for the Treatment of Autoimmune Diseases in Two Back-to-Back Papers in The Journal of Immunology

  Antibody-based therapeutics targeting ILDR2, designated by Compugen as CGEN-15001T, for immuno-oncology were licensed to Bayer.

  February 6, 2018

   · 

  7 min read